Dysregulation of the ghrelin/RANKL/OPG pathway in bone mass is related to AIS osteopenia
- 19 February 2020
- journal article
- research article
- Published by Elsevier BV in Bone
- Vol. 134, 115291
- https://doi.org/10.1016/j.bone.2020.115291
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (81772298)
This publication has 46 references indexed in Scilit:
- Beneficial association of serum ghrelin and peptide YY with bone mineral density in the Newfoundland populationBMC Endocrine Disorders, 2013
- Chronic Central Administration of Ghrelin Increases Bone Mass through a Mechanism Independent of Appetite RegulationPLOS ONE, 2013
- An Age-Dependent Interaction with Leptin Unmasks Ghrelin's Bone-Protective EffectsEndocrinology, 2012
- Top Theories for the Etiopathogenesis of Adolescent Idiopathic ScoliosisJournal of Pediatric Orthopaedics, 2011
- A Meta-Analysis of the Clinical Effectiveness of School Scoliosis ScreeningSpine, 2010
- Expression and modulation of ghrelin O‐acyltransferase in cultured chondrocytesArthritis & Rheumatism, 2009
- Ghrelin inhibits early osteogenic differentiation of C3H10T1/2 cells by suppressing Runx2 expression and enhancing PPARγ and C/EBPα expressionJournal of Cellular Biochemistry, 2009
- Histomorphological study of the spinal growth plates from the convex side and the concave side in adolescent idiopathic scoliosisJournal of Orthopaedic Surgery and Research, 2007
- Decreased Circulating Leptin Level and Its Association With Body and Bone Mass in Girls With Adolescent Idiopathic ScoliosisSpine, 2007
- Generalized Osteopenia in Adolescent Idiopathic Scoliosis–Association With Abnormal Pubertal Growth, Bone Turnover, and Calcium Intake?Spine, 2006